Publication | Open Access

Doxorubicin anti-tumor mechanisms include Hsp60 post-translational modifications leading to the Hsp60/p53 complex dissociation and instauration of replicative senescence

Tumor BiologyHsp60/p53 Complex DissociationDoxorubicin Anti-tumor MechanismsMolecular BiologyCell DeathCellular SenescenceHsp60 Post-translational ModificationsAnti-cancer AgentTumor SuppressorMedicineCell BiologyCancer Research